PG PSYCHOGENICS REDEFINING DRUG DISCOVERY THROUGH INNOVATION
associated with 4 other trademarks
Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on norm...

Words that describe this trademark:

medical scientific research  research field  cognitive motor  scientific research  psychiatric  analgesic  circadian  field  behavioral  neuroprotective 

Serial Number:

88376240

Mark:

PG PSYCHOGENICS REDEFINING DRUG DISCOVERY THROUGH INNOVATION

Status:

Registered

Status Date:

10-08-2019

Filing Date:

Registration Number:

5880034

Registration Date:

10-08-2019

Goods and Services:

Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on normal, mutated, drug-treated or aged animals; Medical and pharmacological phenotype testing; Research services and scientific developments of apparatus for measuring and accessing motor responses on normal, drug-treated or aged animals; Medical and scientific research, namely, pharmaceutical and biotechnological research of human disorders using animal models, specifically, screening and testing of chemical compounds for therapeutic or toxic effects, and capturing, quantifying, processing and storing information on behavioral and physiological changes in animal subjects

Mark Description:

The mark consists of the stylized letters "P" and "G" which combine to form a stick figure which appears to the left of the stylized mark "PsychoGenics". The phrase "Redefining Drug Discovery Through Innovation" appears below in stylized letters.

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

07-23-2019

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

N/A

Business Name:

BALLARD SPAHR LLP

Correspondent Name:

Recent Trademark filings by this company